2017
DOI: 10.18821/0507-4088-2017-62-4-162-168
|View full text |Cite
|
Sign up to set email alerts
|

Dimeric Bisbenzimidazoles Suppress the Herpes Simplex Virus and Human Cytomegalovirus Infections in Cell Сultures

Abstract: Antiviral activity of new AТ-specific fluorescent symmetric dimeric bisbenzimidazoles of DBА(n) series was assessed in the cell models of infections caused by type 1 herpes simplex virus (HSV1) and human cytomegalovirus (CMV). In DBA(n) molecules bisbenzimidazole fragments are bound to an oligomethylene liner with varied number of methylene groups in the linker (n = 1, 3, 5, 7, 9, 11). In contrast to DB(n) dimeric bisbenzimidazoles, in DBA(n) series terminal fragments of macromolecules contain N-dimethylaminop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 20 publications
0
1
0
1
Order By: Relevance
“…Evaluation of antiviral activity of DB 3 P(n) against herpes simplex virus type 1 and cytomegalovirus Antiviral activity of dimeric trisbenzimidazoles DB 3 P(n) was tested on a cell model infected with herpes simplex virus type 1 (HSV-1) and cytomegalovirus (CMV) [23]. Antiviral activity of the compounds was assessed by their capacity to inhibit HSV-infection at different stages of the virus life cycle.…”
Section: Biological Resultsmentioning
confidence: 99%
“…Evaluation of antiviral activity of DB 3 P(n) against herpes simplex virus type 1 and cytomegalovirus Antiviral activity of dimeric trisbenzimidazoles DB 3 P(n) was tested on a cell model infected with herpes simplex virus type 1 (HSV-1) and cytomegalovirus (CMV) [23]. Antiviral activity of the compounds was assessed by their capacity to inhibit HSV-infection at different stages of the virus life cycle.…”
Section: Biological Resultsmentioning
confidence: 99%
“…В качестве положительного контроля использовали ацикловир (АЦВ, Зовиракс ® , «ГлаксоСмитКляйнВэллком», Великобритания) в концентрации 10 мкг/мл, в качестве отрицательного контроля -необработанные зараженные клетки Vero (К1). Оценку противовирусной активности проводили по ингибированию вирус-специфического бляшкообразования путём подсчёта количества инфицированных клеток (бляшек) в опыте и в контроле, как описано ранее [10].…”
Section: материал и методыunclassified